Workflow
AI赋能生物活性原料创新
icon
Search documents
刚刚!欧莱雅投的中国合成生物新贵又拿了数千万融资
Core Viewpoint - The article highlights the successful B+ round financing of the innovative company "未名拾光" (Unnamed Light), which focuses on bioactive raw materials, emphasizing its growth trajectory and the strategic use of AI in its operations [2][4]. Financing Overview - "未名拾光" has completed multiple financing rounds since its establishment in 2021, with the latest B+ round raising several million RMB, following significant investments from major players like 欧莱雅 (L'Oréal) and 纳爱斯集团 (Nais Group) [2][3]. - The company has raised funds in six rounds, with notable amounts including approximately 500 million RMB in the Pre-A round and nearly 1 billion RMB in the A round [3]. Technology and Innovation - The company has developed an "AI + synthetic bio" platform for material innovation, focusing on applications from daily care to medical uses, enhancing product design and production efficiency [4][5]. - The AI engine leverages tools like AlphaFold to improve R&D efficiency, achieving a fivefold increase in development speed for innovative raw materials [5]. Production Capabilities - "未名拾光" employs a dual-cell factory model, utilizing both microbial and plant cell factories to produce various protein products, including peptides and collagen [6]. - The company has successfully induced callus tissue from over 80 rare plant species, with three extracts already registered as new cosmetic raw materials, showcasing industry-leading technology transfer efficiency [6]. Business Model - The company operates under a "self-research + CRDMO" model, focusing on both independent innovation and collaboration with downstream brands for new raw material development [8]. - The approach includes reverse development based on customer needs, particularly in the extraction of rare plant materials, and the creation of specialized collagen types for targeted applications [8]. Future Outlook - The completion of the B+ round financing marks a significant milestone for "未名拾光," indicating a new phase of technological, market, and production capacity development, which is expected to invigorate the industry [8].